| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-08 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-08 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.21 | 1e-06 |